2023 World Conference on Lung Cancer (Posters)-P1.22. Patient Experiences of Biomarker Testing: Insights from a Global Patient Experience Survey

P1.22. Patient Experiences of Biomarker Testing: Insights from a Global Patient Experience Survey - PDF(Slides)

Pdf Summary

A global patient experience survey conducted by the Global Lung Cancer Coalition (GLCC) aimed to understand the experiences of lung cancer patients in accessing biomarker testing. Biomarker testing is crucial in determining the most effective treatment for lung cancer patients. The survey, which received 712 responses from 14 countries, found that the majority of respondents had undergone biomarker testing. However, nearly a fifth of respondents were unaware if they had been tested. This suggests that there may be gaps in patient information and communication about these tests. Additionally, only a small proportion of patients who were tested knew what biomarkers their cancer had, indicating a need for improved communication about test results and their implications. The GLCC emphasizes the importance of informed self-determination for patients and calls for healthcare providers, service providers, and patient support groups to improve communication about biomarker testing. The survey results also revealed that patients from Canada were the most knowledgeable about their biomarker status, with over 75% knowing their test results. The findings highlight the need for better patient education and support to ensure that more patients can access personalized treatment, support, and care based on biomarker testing. The GLCC's patient charter emphasizes the importance of clear communication about test results to enable informed decision-making by patients. The survey findings and detailed breakdown of responses can be found on the GLCC's website.

Asset Subtitle

Jackie Fenemore

Meta Tag

Speaker Jackie Fenemore

Topic Pathology & Biomarkers: Genetic Biomarkers

Keywords

global patient experience survey

Global Lung Cancer Coalition

biomarker testing

lung cancer patients

accessing biomarker testing

patient information

communication

test results

patient education

personalized treatment